130 related articles for article (PubMed ID: 12942921)
1. New ideas for new drug entities.
Mehlhorn H; Kayser O
Parasitol Res; 2003 Jun; 90 Suppl 2():S53-4. PubMed ID: 12942921
[No Abstract] [Full Text] [Related]
2. Designing drugs for parasitic diseases of the developing world.
McKerrow JH
PLoS Med; 2005 Aug; 2(8):e210. PubMed ID: 16120007
[TBL] [Abstract][Full Text] [Related]
3. Achieving the Millennium Development Goals.
Fenwick A; Molyneux D; Nantulya V
Lancet; 2005 Mar 19-25; 365(9464):1029-30. PubMed ID: 15781095
[No Abstract] [Full Text] [Related]
4. Treatment of intestinal parasites in immigrants.
Geltman P; Meyers A
N Engl J Med; 1999 Jul; 341(5):377-8. PubMed ID: 10428671
[No Abstract] [Full Text] [Related]
5. Response from Savioli and colleagues from the Department of Neglected Tropical Diseases, World Health Organization.
Savioli L; Engels D; Daumerie D; Jannin J; Alvar J; Asiedu K; Gastellu-Etchegorry M; Simarro P; Mariotti SP
PLoS Med; 2006 Jun; 3(6):e283. PubMed ID: 16789805
[No Abstract] [Full Text] [Related]
6. Eliminating neglected diseases in Africa.
Hotez P; Bethony J; Brooker S; Albonico M
Lancet; 2005 Jun 18-24; 365(9477):2089. PubMed ID: 15964442
[No Abstract] [Full Text] [Related]
7. Drug development output from 1975 to 1996: what proportion for tropical diseases?
Trouiller P; Olliaro PL
Int J Infect Dis; 1998-1999 Winter; 3(2):61-3. PubMed ID: 10225981
[No Abstract] [Full Text] [Related]
8. The neglected tropical diseases.
Sachs JD
Sci Am; 2007 Jan; 296(1):33A. PubMed ID: 17186830
[No Abstract] [Full Text] [Related]
9. Price hikes could affect treatment for NTDs in the USA.
Nelson R
Lancet Infect Dis; 2018 Feb; 18(2):150-151. PubMed ID: 29412967
[No Abstract] [Full Text] [Related]
10. Drugs for the control of parasitic diseases: current status and development.
Watkins BM
Trends Parasitol; 2003 Nov; 19(11):477-8. PubMed ID: 14580957
[No Abstract] [Full Text] [Related]
11. Reflections on the Nobel Prize for Medicine 2015--The Public Health Legacy and Impact of Avermectin and Artemisinin.
Molyneux DH; Ward SA
Trends Parasitol; 2015 Dec; 31(12):605-607. PubMed ID: 26552892
[TBL] [Abstract][Full Text] [Related]
12. Renewed strategies for drug development against parasitic diseases.
Vial HJ; Traore M; Fairlamb AH; Ridley RG
Parasitol Today; 1999 Oct; 15(10):393-4. PubMed ID: 10481147
[No Abstract] [Full Text] [Related]
13. Infectious diseases. Tackling neglected diseases could offer more bang for the buck.
Vogel G
Science; 2006 Feb; 311(5761):592-3. PubMed ID: 16456044
[No Abstract] [Full Text] [Related]
14. Developing drugs for parasitic diseases.
Andreopoulos S
Science; 2003 Apr; 300(5618):430-1. PubMed ID: 12702858
[No Abstract] [Full Text] [Related]
15. Combinatorial chemistry as a new approach in antiparasitic drug discovery.
Link A
Parasitol Res; 2003 Jun; 90 Suppl 2():S86-90. PubMed ID: 12734752
[TBL] [Abstract][Full Text] [Related]
16. Macrocyclic lactones in antiparasitic therapy. Editorial.
González-Canga A
Curr Pharm Biotechnol; 2012 May; 13(6):851-2. PubMed ID: 22587602
[No Abstract] [Full Text] [Related]
17. The Drug Design & Development Seminar 2024: combining efforts towards human and animal parasitic diseases.
Marhöfer RJ; Noack S; Selzer PM
Trends Parasitol; 2024 Jun; 40(6):439-445. PubMed ID: 38734574
[No Abstract] [Full Text] [Related]
18. Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.
Kayser O; Olbrich C; Croft SL; Kiderlen AF
Parasitol Res; 2003 Jun; 90 Suppl 2():S63-70. PubMed ID: 12937968
[TBL] [Abstract][Full Text] [Related]
19. [Antiparasitic drugs in pediatrics].
Coulaud JP
Ann Pediatr (Paris); 1979 Sep; 26(7):443-7. PubMed ID: 16108252
[No Abstract] [Full Text] [Related]
20. [2015: the Nobel jury reveals research against parasitic diseases].
Nau JY
Rev Med Suisse; 2015 Oct; 11(490):1922-3. PubMed ID: 26665663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
